Diego Cadavid

Company: Verge Genomics

Job title: Chief Medical Officer

Seminars:

Characterizing Safety & Proof-Of-Concept for VRG50635, a Novel Small Molecule Inhibitor ALS Candidate Therapeutic Targeting PIKfyve 11:30 am

Rationale for testing PIKfyve inhibition in ALS Learnings of safety, tolerability and PK/PD in healthy volunteers Design of a novel proof-concept study for the initial investigation of VRG505635 in ALSRead more

day: Day Two Track B AM